NYSE:CVS - CVS Health Stock Price, Price Target & More

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Wednesday, July 11th. Investors of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 annualized dividend and a dividend yield of 3.06%. The ex-dividend date is Tuesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.09. The pharmacy operator earned $45.69 billion during the quarter, compared to analysts' expectations of $45.77 billion. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. The firm's quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.17 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

18 brokers have issued 12-month price targets for CVS Health's shares. Their forecasts range from $68.00 to $99.00. On average, they expect CVS Health's stock price to reach $86.3125 in the next year. This suggests a possible upside of 32.3% from the stock's current price. View Analyst Ratings for CVS Health.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 5 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

CVS Health saw a increase in short interest in June. As of June 29th, there was short interest totalling 43,844,028 shares, an increase of 0.4% from the June 15th total of 43,662,443 shares. Based on an average daily volume of 9,965,640 shares, the short-interest ratio is presently 4.4 days. Currently, 4.3% of the company's shares are sold short. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

News stories about CVS stock have trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVS Health earned a media sentiment score of 0.04 on Accern's scale. They also gave media coverage about the pharmacy operator an impact score of 47.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Bank of Montreal Can (0.40%), Swedbank (0.20%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.13%), DnB Asset Management AS (0.12%) and Retirement Systems of Alabama (0.12%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., Atwood & Palmer Inc., DnB Asset Management AS, Swedbank, Hartford Investment Management Co., Gateway Investment Advisers LLC and Welch & Forbes LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Cornerstone Wealth Management LLC, Howard Capital Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Nikko Asset Management Americas Inc., Factory Mutual Insurance Co., Adams Asset Advisors LLC and TNB Financial. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $65.26.

CVS Health has a market capitalization of $67.24 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]